These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3330252

  • 1. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
    Sznajd J, Malczewska-Malec M, Idzior-Waluś B, Jamska B, Nowacki G.
    Przegl Lek; 1987; 44(12):828-36. PubMed ID: 3330252
    [No Abstract] [Full Text] [Related]

  • 2. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
    Sznajd J, Malczewska-Malec M, Idzior-Waluś B, Iwanejko J, Nowacki G.
    Przegl Lek; 1987; 44(12):837-43. PubMed ID: 3330253
    [No Abstract] [Full Text] [Related]

  • 3. Gemfibrozil--a new lipid lowering agent.
    Nash DT.
    J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
    [Abstract] [Full Text] [Related]

  • 4. Effect of gemfibrozil on serum lipid levels.
    Dahlén G, Gillnäs T, Børresen AL, Berg K, Ericson C.
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [Abstract] [Full Text] [Related]

  • 5. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
    Manninen V.
    Am J Cardiol; 1983 Aug 22; 52(4):35B-38B. PubMed ID: 6351578
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 7. [Gemfibrozil in the treatment of hyperlipoproteinemias].
    Monova D, Petrova V, Belovezhdov N.
    Vutr Boles; 1991 Nov 12; 30(2):56-8. PubMed ID: 1891900
    [Abstract] [Full Text] [Related]

  • 8. [Effect of lipanthyl on parameters of lipid metabolism in patients with primary hyperlipoproteinemia].
    Sznajd J, Magdoń M, Idzior B, Konarska R, Malczewska M, Czarnecka H.
    Przegl Lek; 1984 Nov 12; 41(2):217-21. PubMed ID: 6377392
    [No Abstract] [Full Text] [Related]

  • 9. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 10. Gemfibrozil plus cholestyramine in familial hypercholesterolaemia.
    Jones AF, Hughes EA, Cramb R.
    Lancet; 1988 Apr 02; 1(8588):776. PubMed ID: 2895309
    [No Abstract] [Full Text] [Related]

  • 11. Effects of gemfibrozil on serum lipids.
    Samuel P.
    Am J Med; 1983 May 23; 74(5A):23-7. PubMed ID: 6573843
    [Abstract] [Full Text] [Related]

  • 12. [Long-term therapy of type II and type IV hyperlipoproteinemia using beclobrate].
    Uglesić A, Ljachnicky N.
    Schweiz Rundsch Med Prax; 1988 Jul 05; 77(27-28):755-61. PubMed ID: 3041534
    [No Abstract] [Full Text] [Related]

  • 13. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
    Torstila I, Kaukola S, Manninen V, Virtamo J, Mälkönen M.
    Acta Med Scand Suppl; 1982 Jul 05; 668():123-9. PubMed ID: 6188330
    [Abstract] [Full Text] [Related]

  • 14. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
    Weintraub MS, Eisenberg S, Breslow JL.
    J Clin Invest; 1987 Apr 05; 79(4):1110-9. PubMed ID: 3470306
    [Abstract] [Full Text] [Related]

  • 15. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
    Vega GL, Grundy SM.
    JAMA; 1985 Apr 26; 253(16):2398-403. PubMed ID: 3856692
    [Abstract] [Full Text] [Related]

  • 16. Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.
    Pasternack A, Vänttinen T, Solakivi T, Kuusi T, Korte T.
    Clin Nephrol; 1987 Apr 26; 27(4):163-8. PubMed ID: 3555908
    [Abstract] [Full Text] [Related]

  • 17. Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.
    Houlston R, Quiney J, Watts GF, Lewis B.
    J R Soc Med; 1988 May 26; 81(5):274-6. PubMed ID: 3164409
    [Abstract] [Full Text] [Related]

  • 18. The effect of gemfibrozil on serum lipids in diabetic patients.
    Konttinen A, Kuisma I, Ralli R, Pohjola S, Ojala K.
    Ann Clin Res; 1979 Dec 26; 11(6):240-5. PubMed ID: 398183
    [Abstract] [Full Text] [Related]

  • 19. Gemfibrozil for hyperlipidemia.
    Med Lett Drugs Ther; 1982 Jun 25; 24(612):59-60. PubMed ID: 6953310
    [No Abstract] [Full Text] [Related]

  • 20. Gemfibrozil therapy in patients with coronary heart disease.
    Bell H, Dittmeier G, Martinez L.
    Mo Med; 1988 Jan 25; 85(1):27-30. PubMed ID: 3277032
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.